Carlos Aravena

1.3k total citations
28 papers, 796 citations indexed

About

Carlos Aravena is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Carlos Aravena has authored 28 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Physiology. Recurrent topics in Carlos Aravena's work include Tracheal and airway disorders (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Carlos Aravena is often cited by papers focused on Tracheal and airway disorders (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Carlos Aravena collaborates with scholars based in Chile, United States and Canada. Carlos Aravena's co-authors include Harold R. Collard, Kiran Batra, Ganesh Raghu, Keith C. Meyer, José Torrealba, Julia Kozlitina, Christine Kim Garcia, Craig S. Glazer, Chad A. Newton and Francisco A. Almeida and has published in prestigious journals such as PLoS ONE, Cancer Research and CHEST Journal.

In The Last Decade

Carlos Aravena

26 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Aravena Chile 12 689 293 115 109 70 28 796
Mark Edwin United States 4 777 1.1× 244 0.8× 68 0.6× 74 0.7× 63 0.9× 7 853
Helen E. Jo Australia 13 577 0.8× 240 0.8× 36 0.3× 54 0.5× 48 0.7× 31 606
Kohei Ikezoe Japan 15 538 0.8× 234 0.8× 77 0.7× 57 0.5× 89 1.3× 45 701
Olivia Freynet France 11 393 0.6× 229 0.8× 41 0.4× 24 0.2× 36 0.5× 28 459
Rebecca L. Mortenson United States 8 484 0.7× 184 0.6× 65 0.6× 23 0.2× 44 0.6× 9 535
Jean Charles Dalphin France 6 189 0.3× 107 0.4× 57 0.5× 52 0.5× 25 0.4× 10 435
Laurens De Sadeleer Belgium 12 318 0.5× 135 0.5× 61 0.5× 78 0.7× 33 0.5× 32 406
Ömer Özbudak Türkiye 9 218 0.3× 149 0.5× 105 0.9× 7 0.1× 23 0.3× 33 394
B Fregonese Italy 11 234 0.3× 119 0.4× 136 1.2× 8 0.1× 33 0.5× 24 378
Sumru Beder Türkiye 12 220 0.3× 125 0.4× 99 0.9× 12 0.1× 37 0.5× 28 428

Countries citing papers authored by Carlos Aravena

Since Specialization
Citations

This map shows the geographic impact of Carlos Aravena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Aravena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Aravena more than expected).

Fields of papers citing papers by Carlos Aravena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Aravena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Aravena. The network helps show where Carlos Aravena may publish in the future.

Co-authorship network of co-authors of Carlos Aravena

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Aravena. A scholar is included among the top collaborators of Carlos Aravena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Aravena. Carlos Aravena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tapia, Juan, Naser Damer, Christoph Busch, et al.. (2024). First Competition on Presentation Attack Detection on ID Card. TUbilio (Technical University of Darmstadt). 1–10.
2.
Riquelme, Erick, et al.. (2023). Abstract 651: Revealing the role of lung cancer microbiota in the tumor progression. Cancer Research. 83(7_Supplement). 651–651. 1 indexed citations
3.
Aravena, Carlos & Thomas R. Gildea. (2023). Advancements in airway stents: a comprehensive update. Current Opinion in Pulmonary Medicine. 30(1). 75–83. 5 indexed citations
4.
Aravena, Carlos, et al.. (2023). Innovation in rigid bronchoscopy—past, present, and future. Journal of Thoracic Disease. 15(5). 2836–2847. 5 indexed citations
5.
Aravena, Carlos & Thomas R. Gildea. (2022). Patient-specific airway stent using three-dimensional printing: a review. Annals of Translational Medicine. 11(10). 360–360. 17 indexed citations
6.
Aravena, Carlos, Francisco A. Almeida, Daniel A. Culver, & Manuel L. Ribeiro Neto. (2020). The utility of endobronchial ultrasound-transbronchial needle aspiration in patients with suspected extra-pulmonary sarcoidosis without thoracic lymphadenopathy. Respiratory Medicine. 171. 106074–106074. 4 indexed citations
7.
Moua, Teng, Travis S. Henry, Brett M. Elicker, et al.. (2017). The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 72(5). 424–429. 81 indexed citations
8.
Aravena, Carlos, et al.. (2017). PRIMER REGISTRO DE NEMATODIRUS HELVETIANUS MAY 1920 (NEMATODA: MOLINEIDAE), EN BOVINOS DEL SUR DE CHILE. Neotropical Helminthology. 11(1). 17–23. 1 indexed citations
9.
Labarca, Gonzalo, Carlos Aravena, Francisco Órtega Ruiz, et al.. (2016). Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis. Pulmonary Medicine. 2016. 1–11. 20 indexed citations
10.
Morisset, Julie, Kerri A. Johannson, Eric Vittinghoff, et al.. (2016). Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. CHEST Journal. 151(3). 619–625. 167 indexed citations
11.
Aravena, Carlos, Matthew Hayden, Kevin O. Leslie, et al.. (2016). P065 <break /> Virtual multidisciplinary discussion: Feasibility and diagnostic concordance with face-to-face multidisciplinary discussion. QJM. 1 indexed citations
12.
Andresen, Max, et al.. (2015). Aspergilosis traqueobronquial necrotizante en paciente crítico. Revista médica de Chile. 143(4). 525–530. 1 indexed citations
13.
Aravena, Carlos, et al.. (2015). Correction: Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. PLoS ONE. 10(10). e0140288–e0140288. 19 indexed citations
14.
Aravena, Carlos, et al.. (2015). Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. PLoS ONE. 10(8). e0136160–e0136160. 53 indexed citations
15.
Díaz, Alejandro A., Arturo Morales, Juan Carlos Díaz, et al.. (2013). CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respiratory Medicine. 107(4). 570–579. 46 indexed citations
16.
Florenzano, Pablo, et al.. (2012). Un curso de docencia clínica para residentes mejora la autopercepción de preparación para enseñar. Revista médica de Chile. 140(11). 1431–1436. 3 indexed citations
17.
Domínguez, José Ignacio Barranco, et al.. (2009). Factors That Predict Duration of Delayed Graft Function in Cadaveric Kidney Transplantation. Transplantation Proceedings. 41(6). 2668–2669. 14 indexed citations
18.
Domínguez, José Ignacio Barranco, Rolando Rebolledo, P. Troncoso, et al.. (2009). Duration of Delayed Graft Function Is an Important Predictor of 1-Year Serum Creatinine. Transplantation Proceedings. 41(1). 131–132. 13 indexed citations
19.
Domínguez, José Ignacio Barranco, Rolando Rebolledo, P. Troncoso, et al.. (2008). DURATION OF DELAYED GRAFT FUNCTION IS AN IMPORTANT PREDICTOR OF ONE YEAR SERUM CREATININE. Transplantation. 86(2S). 471–471. 1 indexed citations
20.
Delgado, Carlos, et al.. (2000). Estudio de viabilidad de escólices de quistes hidatídicos hepáticos humanos. Revista Chilena de Cirugía.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026